APRIL GUSTAFSON: Open Payments
NPI 1811473275 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 30 payments from 11 companies in 2025. Trend: 2023 $452 · 2024 $767 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $174 |
| ABBVIE INC. | 4 | $87 |
| Exact Sciences Corporation | 3 | $87 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Amgen Inc. | 3 | $48 |
| GENZYME CORPORATION | 1 | $34 |
| Lilly USA, LLC | 1 | $25 |
| Philips North America LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
Products named: Ozempic, The Cologuard Plus Collection Kit, Wegovy, QULIPTA, OTEZLA, SPRAVATO, KEVZARA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
